A recent Vancouver-based study has revealed troubling findings about Canada’s safer supply programme, which distributes taxpayer-funded hydromorphone—a heroin-strength opioid—to addicts as a safer alternative to toxic street drugs. Conducted by Dr. Brian Conway’s team at Vancouver’s Infectious Disease Centre, the research raises doubts about the programme’s efficacy and accountability.

The study found that nearly a quarter of participants admitted to diverting their prescribed opioids, with 20% selling or trading part of their supply, and 4% diverting all of it. Worryingly, urine tests indicated that 24% of patients had no hydromorphone in their system, suggesting that actual diversion rates may be even higher than self-reported figures. Critics have noted that Canadian urine tests are easy to manipulate, casting further doubt on the reliability of reported diversion rates.

Adding to concerns, the programme seems to be falling short of its core aim—to reduce reliance on street drugs. Fentanyl, a highly potent opioid, was found in 84% of patient urine samples, while 72% tested positive for amphetamines. These findings suggest that street drug use remains prevalent among participants.

While none of the study’s participants experienced fatal or medically significant overdoses, which Conway attributed to the programme, questions were raised about whether this benefit stemmed from safer supply itself or other factors, like the increased income from drug diversion or access to enhanced healthcare. Critics argue these benefits could potentially be achieved through direct financial support, without enabling the black-market circulation of dangerous opioids.

Conway acknowledged that the programme is “not completely safe” and requires refinement, but he defended its role in connecting addicts to healthcare services. However, scepticism remains among experts and observers, with some calling for the initiative to be reconsidered altogether as concerns grow about its unintended consequences, particularly its impact on communities and youth access to diverted drugs.

The findings paint a complex and controversial picture, prompting fresh debate over the future of safer supply in tackling Canada’s addiction crisis.

Source: National Post